BCL11A

BCL11 transcription factor A, the group of BAF complex|Zinc fingers C2H2-type

Basic information

Region (hg38): 2:60450520-60554467

Previous symbols: [ "EVI9" ]

Links

ENSG00000119866NCBI:53335OMIM:606557HGNC:13221Uniprot:Q9H165AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • intellectual disability, autosomal dominant 40 (Definitive), mode of inheritance: AD
  • Dias-Logan syndrome (Strong), mode of inheritance: AD
  • Dias-Logan syndrome (Moderate), mode of inheritance: AD
  • Dias-Logan syndrome (Strong), mode of inheritance: AD
  • Dias-Logan syndrome (Strong), mode of inheritance: AD
  • Dias-Logan syndrome (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Dias-Logan syndromeADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic24810580; 27453576

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the BCL11A gene.

  • not provided (21 variants)
  • Dias-Logan syndrome (14 variants)
  • BCL11A-related BAFopathy (2 variants)
  • Inborn genetic diseases (2 variants)
  • Global developmental delay (1 variants)
  • Postaxial polydactyly;Delayed speech and language development (1 variants)
  • Neurodevelopmental delay (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the BCL11A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
22
clinvar
4
clinvar
30
missense
3
clinvar
7
clinvar
73
clinvar
7
clinvar
2
clinvar
92
nonsense
9
clinvar
4
clinvar
13
start loss
2
clinvar
1
clinvar
3
frameshift
22
clinvar
10
clinvar
32
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
2
clinvar
4
clinvar
1
clinvar
7
splice region
1
1
non coding
2
clinvar
5
clinvar
7
Total 38 26 83 29 11

Variants in BCL11A

This is a list of pathogenic ClinVar variants found in the BCL11A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-60452593-C-G Uncertain significance (May 01, 2022)2650959
2-60452594-G-C Dias-Logan syndrome Uncertain significance (Jan 15, 2020)1030618
2-60452646-G-A Uncertain significance (Dec 01, 2023)3025869
2-60452668-T-G Dias-Logan syndrome Uncertain significance (Feb 07, 2023)1709732
2-60452670-G-GA Dias-Logan syndrome Conflicting classifications of pathogenicity (Aug 01, 2024)992483
2-60458958-GGAGCACAGACATATATACTGCTACTCTTAAAATTCTTTCTCTTCTTTTTTTAAGAATGTCACATTTAAATGCAAGTCTTAAGAATTCATAGTTAATCATCATTGTATCAATATTAGCTTATATACCTGTTCTAGTTTTAAATGGCAAATAGTACCACGTTGTGCTAATAAATCATATTATTTTCTTCTGTTCCCCTCTGTCAAACCTTATTGTCAGCCTCTTCCTTTCAATATGGTATACAAGGTCTTAAAGTTTATCATTTGATTGTCCACTTGACAACCAAGTAGATCTGGATCTATTTCTTTTGGTGCCAGTATTTTTAAAAAGACATTATTAAAGCAAATATCTTCATAAAATGAACTCCTTACTAGTGTATTTAATTGCGTTCCAGGGCTTTTGCACATTACACATTCAATTTAATCATTGTTTAAAAAAAATAAAACTTTGGGCAAAACAGCCCATTTCTTTTAAGCTCTCACCAGGAGCAAAGTAGCTTTTATACTGGTATAATCAGTTTTGTTTATAAAATTAAACTAAAGGAAAAATGATGATTAACTAGGACATAATGGGTCATCTTTTTAGGTAGCCATTGTTGTGAGAAATACAATATAGAATTATATGCTAGTTCCTAAGGTTTATTACCTCACCCAATGCTGAATTAAGCTACAAGTTTATAACAAGTAGAAAGAACCATCGATGTGGTTTTAATAGATCCAAGGCACTCATATTTTAAAACCAAATGATAGAATAAACTTGTTCTGTTTTTCTGTTAATTTGTCAATTCAAGGCCTTTTTTCTTCCTTTCCAATTGATACATTTAACCCTTTAGAGACAGACATTTAGCTCATAGAGATTTTTTTTCAGTGCTATCTATTCTGTCTATAGAGGGTTAATCCAAAGACTGTTTTTCCTCCTCACGTTATAAAATAAAACTGTACATGATATGTATTACAGAATGTATGCAGCATGGTCTTTTTCTCTCTCTCTCTCTTTTTCTCTCAGAACGGAACTGGAAACAGCAACATGTTTGCTCAGCAACGAATTAGGGACAATTTAAAATAGCCATAACATACCATACATGCTGTCTAAGTTTAAAAAAAAACATACACAACATGTAAATTATTGCACAAGAGAAAGGCTCAAAGTTTGCGTAAAATGCAATAGTATTGCCCCATACAGATCATGCATTCAAACGGTGAGAACATAAAGGAAAAAAAAAAAAAAGGAAAAAGAAAAAAGAAAAAGAAAAAGAAAAAAAACAGGTGTGCTGGTGACAAGCACTCTCATATTCTTAGCTTCGTTACTTCTGTTTGTTTGTTTGTTTGTTTAAATCACATGGGACTAGAAAAAAATCCTACAGGGAGTGGGGCTGGAGGGCGATGGGGAAGGGGAGTGGTGAAAAAGGGGGTGTCAGGTGGGAGTGAGGGAGGGGTATTAATATACCTCTATTCAGTTTTTATATCATTATTCAACACTCGATCACTGTGCCATTTTTTCATGTGTTTCTCCAGGGTACTGTACACGCTAAAAGGCATCTTACAAATTTCACATTTGTAAACGTCCTTCCCCACCTGGCCATGCGTTTTCATGTGCCTGGTGAGCTTGCTACTCTGGGCACAGGCATAGTTGCACAGCTCGCATTTATAAGGCCTTTCGCCCGTGTGGCTTCTCCTGTGGACAGTGAGATTGCTACAGTTCTTGAAGACTTTCCCACAGTACTCACAAGTGTCGCTGCGTCTGCCCTCTTTTGAGCTGGGCCTGCCCGGGCCCGGACCACTAATATGGGGCGTGCTCCCTCCACTTCCCGTGCCGCTGCGCCCCGAGATCCCTCCGTCCAGCTCCCCGGGCGGTGTGGAGAAGCGCAAACTCCCGTTCTCCGAGGAGTGCTCCGACGAGGAGGCAAAAGGCGATTGTCTGGAGTCTCCGAAGCTAAGGAAGGGATCTTTGAGCTGCCTGGAGGCCGCGTAGCCGGCGAGCCACTGCGAGTACACGTTCTCCGTGTTGGGCATCGCGGCCGGGGGCAGGTCGAACTCCTTCTCGAGCTTGATGCGCTTAGAGAAGGGGCTCAGCGAGCTGGGGCTGCCCAGCAGCAGCTTTTTGGACAGGCCCCCCGAGGCCGACTCGCCCGGGGAGCAGCCGCGGCCATTAACAGTGCCATCGTCTATGCGGTCCGACTCGCCGGCCACCGAGTCTTCGTCGCAAGTGTCCCTGTGGCCCTCGGCCTCGGCCAGGTGGCCGCGCTTATGCTTCTCGCCCAGGACCTGGTGGAAGGCCTCGCT-G Intellectual disability Likely pathogenic (Dec 18, 2023)2672314
2-60460419-A-C Inborn genetic diseases Uncertain significance (Mar 30, 2024)3260633
2-60460441-C-T Uncertain significance (Aug 29, 2022)2442747
2-60460471-G-A Uncertain significance (Mar 30, 2023)2582060
2-60460508-ATTT-A Uncertain significance (Nov 07, 2019)1310190
2-60460539-C-T Likely benign (Aug 01, 2022)2650960
2-60460550-G-A Pathogenic (Apr 09, 2023)2497886
2-60460575-A-C Uncertain significance (Oct 16, 2020)1313401
2-60460618-G-A Uncertain significance (Apr 20, 2023)2662857
2-60460656-C-G Uncertain significance (Feb 11, 2023)2576810
2-60460661-A-G Uncertain significance (Dec 07, 2023)3252362
2-60460700-C-T Inborn genetic diseases Uncertain significance (May 26, 2024)3260632
2-60460717-C-CT Inborn genetic diseases Likely pathogenic (Aug 10, 2018)985399
2-60460724-G-T Dias-Logan syndrome • Inborn genetic diseases Uncertain significance (Nov 02, 2023)2439486
2-60460726-C-T Inborn genetic diseases • BCL11A-related disorder Uncertain significance (Dec 07, 2021)2265697
2-60460751-T-C Inborn genetic diseases Uncertain significance (Dec 20, 2021)2268059
2-60460765-G-A Uncertain significance (Feb 13, 2024)3342561
2-60460765-G-C Uncertain significance (Sep 01, 2022)2650961
2-60460772-T-C Uncertain significance (Dec 05, 2023)3364940
2-60460774-C-T Dias-Logan syndrome Uncertain significance (Jan 24, 2022)1683715

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
BCL11Aprotein_codingprotein_codingENST00000335712 4102401
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9700.0300125742051257470.0000199
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.832965490.5390.00003715477
Missense in Polyphen70164.220.426271750
Synonymous2.102162590.8340.00002171646
Loss of Function3.98324.10.1250.00000110304

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004630.0000462
European (Non-Finnish)0.00002640.0000264
Middle Eastern0.000.00
South Asian0.00003280.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcription factor associated with the BAF SWI/SNF chromatin remodeling complex (By similarity). Repressor of fetal hemoglobin (HbF) level (PubMed:26375765). Involved in brain development (PubMed:27453576). Functions as a myeloid and B-cell proto-oncogene. May play important roles in leukemogenesis and hematopoiesis. Essential factor in lymphopoiesis required for B- cell formation in fetal liver. May function as a modulator of the transcriptional repression activity of ARP1 (By similarity). {ECO:0000250|UniProtKB:Q9QYE3, ECO:0000303|PubMed:26375765, ECO:0000303|PubMed:27453576}.;
Disease
DISEASE: Note=Chromosomal aberrations involving BCL11A may be a cause of lymphoid malignancies. Translocation t(2;14)(p13;q32.3) causes BCL11A deregulation and amplification. {ECO:0000269|PubMed:11719382}.; DISEASE: Intellectual developmental disorder with persistence of fetal hemoglobin (IDPFH) [MIM:617101]: An autosomal dominant disorder characterized by delayed psychomotor development, intellectual disability, variable dysmorphic features, including microcephaly, downslanting palpebral fissures, strabismus, and external ear abnormalities, and asymptomatic persistence of fetal hemoglobin. {ECO:0000269|PubMed:27453576}. Note=The disease is caused by mutations affecting the gene represented in this entry. {ECO:0000269|PubMed:27453576}.;
Pathway
Prion disease pathway (Consensus)

Recessive Scores

pRec
0.170

Intolerance Scores

loftool
0.0194
rvis_EVS
-1.16
rvis_percentile_EVS
6.17

Haploinsufficiency Scores

pHI
0.669
hipred
Y
hipred_score
0.628
ghis
0.586

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
1.00

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Bcl11a
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;

Zebrafish Information Network

Gene name
bcl11ab
Affected structure
trunk
Phenotype tag
abnormal
Phenotype quality
morphology

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;positive regulation of gene expression;protein sumoylation;negative regulation of dendrite extension;negative regulation of neuron remodeling;cellular response to L-glutamate;negative regulation of dendrite development;negative regulation of branching morphogenesis of a nerve
Cellular component
nucleus;nucleoplasm;cytoplasm;postsynaptic density
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein kinase binding;sequence-specific DNA binding;metal ion binding